WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010028275) METHODS FOR TREATING OR PREVENTING IL-1ß RELATED DISEASES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/028275    International Application No.:    PCT/US2009/056086
Publication Date: 11.03.2010 International Filing Date: 04.09.2009
IPC:
A61K 39/395 (2006.01)
Applicants: XOMA TECHNOLOGY LTD. [US/US]; c/o XOMA (US) LLC 2910 Seventh Street Berkeley, CA 94710 (US) (For All Designated States Except US).
SCANNON, Patrick, J. [US/US]; (US) (For US Only).
SOLINGER, Alan, M. [US/US]; (US) (For US Only).
BAUER, Robert, J. [US/US]; (US) (For US Only)
Inventors: SCANNON, Patrick, J.; (US).
SOLINGER, Alan, M.; (US).
BAUER, Robert, J.; (US)
Agent: BETTI, Christopher; (US)
Priority Data:
61/094,842 05.09.2008 US
61/094,857 05.09.2008 US
61/121,451 10.12.2008 US
61/121,486 10.12.2008 US
Title (EN) METHODS FOR TREATING OR PREVENTING IL-1ß RELATED DISEASES
(FR) PROCÉDÉS POUR LE TRAITEMENT OU LA PRÉVENTION DES MALADIES ASSOCIÉES À IL-1SS
Abstract: front page image
(EN)Disclosed are methods for the treatment and/or prevention of Type 2 diabetes, insulin resistance and disease states and conditions characterized by insulin resistance, decreased insulin production, hyperglycemia, hypoinsulinemia, metabolic syndrome, Type 1 diabetes and obesity, comprising administering to a subject an effective amount of anti-IL-1 antibody or fragment thereof.
(FR)La présente invention a pour objet des procédés pour le traitement et/ou la prévention du diabète de Type 2, de la résistance à l’insuline et des états pathologiques et troubles caractérisés par une résistance à l’insuline, une production d’insuline diminuée, une hyperglycémie, une hypoinsulinémie, un syndrome métabolique, un diabète de Type 1 et une obésité, comprenant l’administration à un sujet d’une quantité efficace d’anticorps anti-IL-1 ou d’un fragment de cet anticorps.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)